万孚生物公告，预计2025年度归属于上市公司股东的净利润为4600万元-6900万元，同比下降 87.71%-91.81%。公司主营业务收入同比下滑，主要原因是国内收入下滑，一方面增值税税率调整影 响，另一方面院内业务受到医疗行业政策影响，量价承压；海外业务发展稳健，为公司整体的可持续增 长提供了重要支撑点。 ...

Core Viewpoint - The company, Xiwang Food, is projecting a net profit loss for the period from January 1, 2025, to June 30, 2025, with expected losses ranging from 15 million to 25 million yuan, compared to a profit of 40.65 million yuan in the same period last year [1] Financial Performance - The net profit attributable to shareholders is expected to be a loss of 15 million to 25 million yuan, while the same period last year showed a profit of 40.65 million yuan [1] - The net profit after deducting non-recurring gains and losses is projected to be a loss of 18 million to 30 million yuan, compared to a profit of 52.76 million yuan in the previous year [1] - The basic earnings per share are expected to be a loss of 0.014 to 0.025 yuan per share, while the previous year reported earnings of 0.0377 yuan per share [1] Business Challenges - The company is facing challenges in its edible oil and sports nutrition businesses, with revenue declines attributed to intense market competition, online competitor subsidies, and adjustments by distributors [1] - High raw material prices are maintaining pressure on the company's gross margin, leading to a decrease in profitability [1]